** Shares of Abbott Laboratories ABT.N fall 1.1% to $115.50 premarket
** Medical device maker forecasts 2025 adj. EPS at $5.05 to $5.25, with its midpoint mostly in line with Wall Street estimates of $5.16, data compiled by LSEG shows
** Company expects Q1 adj. EPS to be between $1.05 and $1.09, below estimates of $1.11
** Q4 adj. EPS of $1.34 meets estimates
** Shares rose 2.8% in 2024
(Reporting by Puyaan Singh and Sriparna Roy in Bengaluru)
((Puyaan.Singh@thomsonreuters.com;))